6 well plate - cellcuture with medium

Helmholtz Munich contributes to the National Strategy for Gene and Cell Therapies

Transfer IDR VIRO

On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.

Developed by the Berlin Institute of Health (BIH) at Charité on behalf of the Federal Ministry of Education and Research (BMBF), the strategy paper incorporates insights from approximately 150 experts across science, industry, politics, and society. Federal Minister Bettina Stark-Watzinger received the paper during the event, which also featured discussions and presentations, including one by Prof. Ulrike Protzer, Head of Virology at Helmholtz Munich. The strategy aims to advance socially significant progress in gene and cell-based therapies.

More information:

Read news in German

Read the National Strategy for Gene and Cell Therapie (pdf) 

Read Press Release of BIH 

20211209_Prof_Protzer_Astrid Eckert-110_freigestellt
Prof. Dr. Ulrike Protzer

Deputy Head of the Molecular Targets and Therapeutics Center, Director Virology

View profile
Prof. Dr. Heiko Lickert_freigestellt
Prof. Dr. Heiko Lickert

Institute Director

View profile

Related news

Expert Hour 4

Events, Public Engagement, Diabetes, HI-MAG, IDR,

Helmholtz Munich zu Gast im Bundestag: Durchbrüche bei den Volkskrankheiten Adipositas und Diabetes

In der 2. Helmholtz Munich Expert Hour trafen sich am 10. April 2024 erneut Vertreter:innen aus Politik und Wissenschaft, um über drängende Gesundheitsthemen zu diskutieren und sich über die neuesten Entwicklungen in der Forschung zu informieren. Im…

Close-up medical syringe with a vaccine.

Molecular Targets and Therapeutics, VIRO,

On the Trail of New Vaccines

Several research groups at Helmholtz Munich are working on innovative vaccines. Two of them are about to clear a crucial hurdle before approval - fighting the Epstein-Barr virus and Hepatitis B. But how do researchers develop a vaccine?

Pancreatic organoids on newly developed chip platform

Pioneer Campus,

Organ-on-Chip: Micro-Organs for Personalised Cell Therapy

They fit in the palm of your hand – tiny mini-labs that researchers at Helmholtz Munich want to use to shape the medicine of tomorrow. “Organ-on-chip” is the key word. This approach combines engineering and biology, not only making it easier to…

share share share mail